http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2351637-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b556644ce456cbf13d3421e2ebd84e8b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505 |
| filingDate | 1999-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87ecc0bcec7a83c94e656f08bc3defdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_156f752d86b31227e46c642926aa6502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b43a0d7748879d433031952142caf6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0b4ec886ab15f50bfede483ef7ca5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4218cc2de18dc7dfabdcdb51ff63af03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41010c53bd56a94ad5e8b6ad65719233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63be9adb24927d70609057282d1bf85b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36010717e314527773408bc54c4abefe |
| publicationDate | 2000-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2351637-A1 |
| titleOfInvention | Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof |
| abstract | The invention relates to novel recombinant glycoproteins that act as messeng er substances, signaling substances, promoters, stimulators and initiators in a multitude of ways in the animal, especially human, circulation system. The invention also relates to a method for the production thereof, pharmaceutica l agents containing said glycoproteins and the use thereof. The invention more particularly relates to novel recombinant human glycoproteins (rh glycoproteins), preferably novel rh differentiation factors, especially rh erythropoietin; novel rh growth factors, especially rh CSF (colony stimulati ng factor), rh GMCSF (granulocyte monocyte stimulation factor); novel rh thrombolytic agents, especially rh tPA (tissue plasminogen activator) and rh urokinase; novel rh thromboprophylactic agents, especially rh antithrombin III; novel rh coagulation factors, especially rh factor VIII and rh factor I X; novel rh interferons, especially rh .alpha., .beta. and .gamma. interferons; and novel rh interleukins, especially rh IL-2, IL-15, IL-16 and IL-17. The invention further relates to a method for the production of said substances, pharmaceutical agents containing them and to the use thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7645609-B2 |
| priorityDate | 1998-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 426.